AI Bias Analysis
4 models · Takes ~15 seconds
Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- Cardiovascular protection with GLP-1 receptor agonists may benefit patients undergoing certain transcatheter procedures, according to two observational studies. When used as an adjunct to transcatheter aortic valve replacement...
(MedPage Today) -- The investigational cell therapy deramiocel slowed upper limb functional decline in boys and young men with Duchenne muscular dystrophy, data from the phase III HOPE-3 trial showed. At 12 months, the mean percent change from...
(MedPage Today) -- Discussions at the American Academy of Dermatology annual meeting about chronic spontaneous urticaria (CSU) highlighted evolving skin-directed and immune-targeted therapies, but new research is challenging the view of CSU as...
(MedPage Today) -- The FDA said Friday it will offer ultra-fast review to three psychedelic drugs being developed for hard-to-treat forms of depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward...
